Genomic Health Settles Medicare Fraud Allegations for $32.5 Million
- October 06, 2023
Genomic Health, Inc. (GHI) will pay $32.5 million to settle allegations under the False Claims Act (FCA) that it tried to evade Medicare billing rules for cancer genetic tests, the Department of Justice announced October 2.
ARTICLE TAGS
You must be logged in to access this content.